Literature DB >> 9581588

Management of Barrett's esophagus.

A J Cameron1.   

Abstract

In Barrett's esophagus, the squamous lining of the lower esophagus is replaced by columnar epithelium. Barrett's esophagus is associated with gastroesophageal reflux and an increased risk of the development of esophageal cancer. Endoscopy shows red columnar epithelium in the lower esophagus. Biopsy is needed to confirm intestinal metaplasia. Some cases progress from dysplasia to invasive adenocarcinoma. Medical or surgical antireflux treatment controls symptoms and esophagitis, but Barrett's esophagus remains. Patients are usually followed up by endoscopy for detection of dysplasia or early cancer. For patients with low-grade dysplasia, follow-up is adequate; however, for those with high-grade dysplasia, esophagectomy or experimental endoscopic mucosal ablation is advised.

Entities:  

Mesh:

Year:  1998        PMID: 9581588     DOI: 10.1016/S0025-6196(11)63730-0

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  11 in total

1.  Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's esophagus.

Authors:  Rebecca E Rudolph; Thomas L Vaughan; Alan R Kristal; Patricia L Blount; Douglas S Levine; Patricia C Galipeau; Laura J Prevo; Carissa A Sanchez; Peter S Rabinovitch; Brian J Reid
Journal:  J Natl Cancer Inst       Date:  2003-05-21       Impact factor: 13.506

2.  Carcinogenesis of Barrett's esophagus: a review of the clinical literature.

Authors:  Jiro Watari; Tadayuki Oshima; Hirokazu Fukui; Toshihiko Tomita; Hiroto Miwa
Journal:  Clin J Gastroenterol       Date:  2013-08-14

3.  Multispectral scanning during endoscopy guides biopsy of dysplasia in Barrett's esophagus.

Authors:  Le Qiu; Douglas K Pleskow; Ram Chuttani; Edward Vitkin; Jan Leyden; Nuri Ozden; Sara Itani; Lianyu Guo; Alana Sacks; Jeffrey D Goldsmith; Mark D Modell; Eugene B Hanlon; Irving Itzkan; Lev T Perelman
Journal:  Nat Med       Date:  2010-04-11       Impact factor: 53.440

4.  Dysplasia in Barrett's Esophagus.

Authors:  Marcos Pedrosa
Journal:  Curr Treat Options Gastroenterol       Date:  2001-02

5.  Wide-field optical property mapping and structured light imaging of the esophagus with spatial frequency domain imaging.

Authors:  Jordan A Sweer; Mason T Chen; Kevan J Salimian; Richard J Battafarano; Nicholas J Durr
Journal:  J Biophotonics       Date:  2019-06-14       Impact factor: 3.207

Review 6.  MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Takatsugu Kan; Stephen J Meltzer
Journal:  Curr Opin Pharmacol       Date:  2009-09-19       Impact factor: 5.547

7.  A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus.

Authors:  Zhe Jin; Yulan Cheng; Wen Gu; Yingye Zheng; Fumiaki Sato; Yuriko Mori; Alexandru V Olaru; Bogdan C Paun; Jian Yang; Takatsugu Kan; Tetsuo Ito; James P Hamilton; Florin M Selaru; Rachana Agarwal; Stefan David; John M Abraham; Herbert C Wolfsen; Michael B Wallace; Nicholas J Shaheen; Kay Washington; Jean Wang; Marcia Irene Canto; Achyut Bhattacharyya; Mark A Nelson; Paul D Wagner; Yvonne Romero; Kenneth K Wang; Ziding Feng; Richard E Sampliner; Stephen J Meltzer
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

Review 8.  Adenocarcinoma appearing very late after antireflux surgery for Barrett's esophagus: long-term follow-up, review of the literature, and addition of six patients.

Authors:  Attila Csendes; Patricio Burdiles; Italo Braghetto; Owen Korn
Journal:  J Gastrointest Surg       Date:  2004 May-Jun       Impact factor: 3.452

Review 9.  Surgical treatment of Barrett's esophagus: 1980-2003.

Authors:  Attila Csendes
Journal:  World J Surg       Date:  2004-02-17       Impact factor: 3.352

10.  Narrow-band pass filter array for integrated opto-electronic spectroscopy detectors to assess esophageal tissue.

Authors:  Débora S Ferreira; Jelena Mirkovic; Reinoud F Wolffenbuttel; José H Correia; Michael S Feld; Graça Minas
Journal:  Biomed Opt Express       Date:  2011-05-25       Impact factor: 3.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.